AICentralResources
AI Tool Comparison

Comparing as AI Medical Research & Clinical Decision Support
Recursion Pharmaceuticals vs Suki AI

Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.

Recursion Pharmaceuticals

Recursion Pharmaceuticals

VS
Suki AI

Suki AI

Verdict by Category

AI content generation failed. Refresh the page to try again.
View Recursion Pharmaceuticals View Suki AI

Detailed Comparison

Feature
Recursion Pharmaceuticals
Suki AI
Pricing
CustomRecursion operates through three revenue streams: pharma collaboration agreements, data licensing, and its own internal drug pipeline. Pharma partnerships (Roche/Genentech, Sanofi) are structured as multi-year agreements with upfront payments and milestone-based payments tied to program progress. Recursion has earned $500M+ in cumulative milestones to date, with $134M from Sanofi alone. Data licensing allows external researchers and pharma companies to access Recursion's proprietary biology maps and phenomics datasets for their own target discovery programs. Recursion's own clinical programs (REC-4881, REC-1245, REC-4539) will generate revenue through future partnering, co-development, or commercialization deals as they advance through clinical trials. Total 2025 revenue: $74.7M. Contact Recursion through recursion.com for partnership inquiries.
CustomSuki does not publish pricing on its official website; every path (Suki for Clinicians and Suki for Partners) leads to a "Contact Us" sales conversation rather than a self-serve checkout. Third-party trade coverage and reseller listings throughout 2025-2026 consistently report two tiers: Suki Compose (documentation-only, works with any EHR) at roughly $299 per provider per month, and the full Suki Assistant (deep EHR integration, voice commands, coding, and clinical Q&A) at roughly $399 per provider per month. Enterprise health-system contracts are negotiated separately with volume and specialty-based discounts, and some independent reviews report additional setup fees in the $500-$2,000 range plus annual contract commitments. Exact pricing requires a conversation with Suki's sales team.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Productivity ToolsAI Developer APIs & Platforms
Summary
AI-native drug discovery OS with industrial-scale automated labs and $500M+ in pharma partnerships
Ambient clinical AI that turns patient visits into notes, coding, and voice-driven workflows
Recursion Pharmaceuticals

Recursion Pharmaceuticals Pros & Cons

Pros

  • $500M+ in pharma partnership milestones — most validated AI drug platform by commercial revenue
  • Recursion OS is the most vertically integrated AI drug discovery system — biology to clinic in one platform
  • Industrial-scale automated labs generate data no other company can replicate
  • Phase 2 FAP clinical proof of concept — 53% polyp reduction — FDA registration discussions began
  • Roche/Genentech and Sanofi as partners — two of the world's top 5 pharma companies
  • Exscientia acquisition in 2024 added cutting-edge small molecule AI design capabilities
  • Cash runway guided into early 2028 — disciplined capital allocation

Cons

  • Stock (RXRX) is below $5 — significant market skepticism on timeline to commercial drugs
  • Operating cash burn of ~$390M in 2026 — needs continued capital or milestone payments
  • Acquired Exscientia in 2024 — integration complexity and added operational overhead
  • No approved drugs yet — clinical proof of concept still early stage
  • Proprietary platform requires industrial-scale automation infrastructure that can't be self-built
Suki AI

Suki AI Pros & Cons

Pros

  • Genuine voice-command interface goes beyond passive transcription, letting clinicians drive the EHR by voice
  • Combines documentation, coding, and clinical Q&A in one platform instead of separate point tools
  • Deep, bi-directional integration with the four leading EHRs: Epic, Oracle Health, athenahealth, and MEDITECH
  • Backed by independent KLAS validation of clinical and financial ROI
  • Broad specialty and care-setting coverage, from ambulatory and inpatient to telehealth and home health
  • Suki for Partners lets healthtech companies embed the same ambient AI via APIs and SDKs

Cons

  • No public pricing or free tier; every path on the website leads to a sales demo and a typically annual enterprise contract
  • Reported per-provider pricing (roughly $299-$399/month) runs meaningfully higher than several budget-focused competitors
  • Enterprise-style deployment and contracting can be heavier than solo clinicians or small practices need
  • Learning the voice-command workflow adds a slight learning curve compared with purely passive ambient scribes
  • Doesn't cover adjacent front-office tasks like patient call answering, fax management, or payment collection